42492-62-6Relevant articles and documents
Hepatitis C Virus Inhibitors
-
Page/Page column 47, (2008/06/13)
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Is there a scaffolding domain within the structure of the immunosuppressive agent cyclosporin A (CsA)? Studies of the cyclophilin binding domain of CsA
Schreiber,Anthony,Dorsey,Hawley
, p. 6577 - 6580 (2007/10/02)
-